| A Clinical Study of KH001 for Pulp Preservation and Safety in Deep Dentin Caries (NCT07751016) | Seoul National University Dental Hospital | 2026-09-30 |
| Metronomic Decitabine-Cedazuridine and Venetoclax in R/R AML, HR-MDS, HR/AP MPN (NCT07710534) | Virginia Commonwealth University | 2026-09-30 |
| Trastuzumab Rezetecan Followed by Pyrotinib, and Trastuzumab Combined With Capecitabine as First-line Treatment for Advanced HER2-positive Breast Cancer (NCT07766772) | Fujian Cancer Hospital | 2026-09-30 |
| Intra Articular Injection of Peripheral Blood Mononuclear Cells for Knee Osteoarthritis (NCT07703280) | DuoGenic StemCells Corporation (DGSC) | 2026-09-30 |
| Fecal Microbiota Transplant(FMT) Combination With Tislelizumab in Advanced or Metastatic NSCLC (NCT07432984) | Se-Hoon Lee | 2026-09-30 |
| Survivin-Targeted Dendritic Cell (DC) Cell Injection for Newly Diagnosed Glioblastoma (NCT07715097) | Beijing Tricision Biotherapeutics Inc | 2026-09-30 |
| Ficerafusp Alfa, Pembrolizumab, and Stereotactic Body Radiotherapy (SBRT) for Head and Neck Squamous Cell Carcinoma (HNSCC) (NCT07552558) | Washington University School of Medicine | 2026-09-30 |
| Ropeginterferon Alfa-2b for the Treatment of Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes and Chronic Myelomonocytic Leukemia (NCT07468916) | Jonsson Comprehensive Cancer Center | 2026-09-29 |
| Study to Evaluate the Efficacy and Safety of Nizubaglustat (AZ-3102) in Patients With Gaucher Disease Type 3 (GD3) (NCT07715084) | Azafaros B.V. | 2026-09-28 |
| Phase 2 Trial Of Sacituzumab Tirumotecan For Treatment Of Refractory Metastatic Or Unresectable Squamous Cell Carcinoma Of The Anus/Rectum (NCT07511023) | M.D. Anderson Cancer Center | 2026-09-25 |
| A Study of JNJ-95597528 in Participants With Inadequately Controlled Moderate to Severe Asthma (NCT07746687) | Janssen Research & Development, LLC | 2026-09-23 |
| Comparing 123I-MIBG and 18F-MFBG Imaging in Patients With Newly Diagnosed, High Risk Neuroblastoma (NCT06858501) | Children's Oncology Group | 2026-09-22 |
| A Study to Assess Adverse Events and Change in Disease Activity With Treatment Combinations With Telisotuzumab Adizutecan in Adults Participants With Pancreatobiliary Cancers (NCT07769502) | AbbVie | 2026-09-22 |
| Bempedoic Acid Therapy for Polycystic Kidney Disease (NCT07282821) | Kenneth Hallows | 2026-09-21 |
| An Open-label Long-term Safety Study of Buntanetap in Participants With AD (NCT07757204) | Annovis Bio Inc. | 2026-09-21 |
| A Clinical Trial of Bomedemstat in Participants With Polycythemia Vera (MK-3543-025) (NCT07722611) | Merck Sharp & Dohme LLC | 2026-09-21 |
| S243249 Monotherapy in Patients With Relapsed or Refractory Acute Leukemia With a KMT2A or NUP98 Translocation or Relapsed or Refractory AML With NPM1c Mutation (NCT07722312) | Servier | 2026-09-20 |
| Clinical Trial Evaluating the Biological Activity of a New Drug Identified as Prifetrastat (PF-07248144), Combined With Fulvestrant for the Treatment of Patients With Hormone Receptor Positive (HR+) and HER2 Negative (HER2-) Breast Cancer Extended to Other Organs. (NCT07340619) | UNICANCER | 2026-09-18 |
| Epcoritamab in Combination With Dose Adjusted EPOCH-R for High-risk Burkitt Lymphoma (BL), The BEDROCK Study (NCT07662928) | AIDS Malignancy Consortium | 2026-09-17 |
| Nirogacestat in Patients With Kaposi Sarcoma (NCT07539454) | AIDS Malignancy Consortium | 2026-09-17 |
| CAIX PET/CT for Residual or Recurrent Post-ablative ccRCC (NCT07077083) | Massachusetts General Hospital | 2026-09-16 |
| Phase Ib/II Study of SYS6020 in Relapsing/Refractory Multiple Sclerosis (NCT07756268) | Tongji Hospital | 2026-09-16 |
| Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a Myelin Repair Therapy (NCT06065670) | University of California, San Francisco | 2026-09-15 |
| A Study to Evaluate S241656 Alone or in Combination in Participants With Selected Myeloid Malignancies (NCT07719348) | Servier | 2026-09-15 |
| Tirzepatide for Treatment of CCCA (NCT07734870) | Johns Hopkins University | 2026-09-15 |
| Safety and Preliminary Diagnostic Performance of [⁶⁴Cu]Cu-RAX301 in Prostate Cancer (NCT07765940) | RadAlliance Therapeutics, Inc | 2026-09-15 |
| A Study to Evaluate the Safety and Efficacy of AC01 Compared to Placebo in Participants With Chronic Heart Failure (NCT07584967) | AnaCardio AB | 2026-09-15 |
| A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis (NCT07412704) | Bristol-Myers Squibb | 2026-09-15 |
| CS1 Added to Standard of Care Therapy for Pulmonary Arterial Hypertension (NCT07761572) | Cereno Scientific AB | 2026-09-15 |
| Treatment in Patients With Advanced Non-Small Cell Lung Carcinoma and Interstitial Lung Disease (NCT07420439) | Intergroupe Francophone de Cancerologie Thoracique | 2026-09-15 |
| Study for Evaluating the Safety and Feasibility of Fecal Microbiota Transplant in Stage II-III NSCLC Patients Using ICI Responders as Donors (MIGRANT) (NCT07247786) | Fundación GECP | 2026-09-15 |
| Partial Immune-boost TACE in unrEseCTable HCC Patients Under Systemic Treatment (NCT07168668) | Chang Gung Memorial Hospital | 2026-09-15 |
| Augmenting Cerebral Blood Flow in Acute Ischemic Stroke (NCT06911385) | University of Alberta | 2026-09-15 |
| Psilocybin With Psychotherapy for Improving Chronic Pain in Cancer Patients Requiring Opioids (NCT06827054) | Roswell Park Cancer Institute | 2026-09-15 |
| Treatment of CKD Patients With HCV (NCT07770984) | Tanta University | 2026-09-15 |
| EFFICACY AND SAFETY OF ZOLEDRONATE VERSUS PLACEBO ON PAIN AT WEEK 12 IN PEDIATRIC PATIENTS WITH CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS (NCT07668583) | Assistance Publique - Hôpitaux de Paris | 2026-09-15 |
| Safety and Efficacy of KER-065 in Participants With Duchenne Muscular Dystrophy (NCT07704099) | Keros Therapeutics, Inc. | 2026-09-14 |
| Medical Imaging to Re-evaluate Elacestrant Clinical Usage (NCT07753954) | Jules Bordet Institute | 2026-09-13 |
| Testing the Anti-Cancer Drug, Brenetafusp (IMCF106C), in Rare Cancers (NCT07686367) | National Cancer Institute (NCI) | 2026-09-11 |
| Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy (NCT07504588) | National Cancer Institute (NCI) | 2026-09-10 |
| Phase 2 Open Label Trial of Delgocitinib 20 mg/g Cream in Subjects With Frontal Fibrosing Alopecia (FFA) (NCT07671157) | Maryanne Makredes Senna | 2026-09-10 |
| A Study of Efficacy and Safety of TLL-018 in CSU Participants With Inadequate Response to 2nd-generation H1-AHs (NCT07764003) | Hangzhou Highlightll Pharmaceutical Co., Ltd | 2026-09-10 |
| Ziftomenib for the Treatment of Patients With NPM1 Mutated or KMT2A Rearranged Acute Myeloid Leukemia Not Eligible for Standard Therapy (NCT06930352) | Uma Borate | 2026-09-10 |
| Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk for Breast Cancer (NCT07499999) | Dana-Farber Cancer Institute | 2026-09-09 |
| Fentanyl Intranasal for Retinopathy of Prematurity Screening in Preterm Infants (NCT07112430) | Marsha Campbell-Yeo | 2026-09-09 |
| First-line Therapy With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor(EGFR-TKI) Combined With Trastuzumab Rezetecan for Advanced Non-small Cell Lung Cancer(NSCLC) Harboring EGFR Mutations Concomitant With Human Epidermal Growth Factor Receptor 2(HER2) Alterations (NCT07699952) | Yongsheng Wang | 2026-09-09 |
| A Study of Risvutatug Rezetecan in Combination With Ivonescimab in Participants With Advanced Solid Tumors (EMBOLD PanTumour-103) (NCT07602855) | GlaxoSmithKline | 2026-09-08 |
| Psilocybin for Treatment of OCD-2 (NCT06992999) | Francisco A Moreno | 2026-09-08 |
| Testing the Combination of Anti-Cancer Drugs, Selumetinib and DS-8201a, for Advanced Pancreatic Ductal Adenocarcinoma (NCT07619521) | National Cancer Institute (NCI) | 2026-09-08 |
| rBCG-N-RSV Vaccine in Adults Aged 60 Years and Older (NCT07762014) | Biothervax SpA | 2026-09-07 |
| Impact of Exogenous Ketones on Sleep Apnea (NCT06687655) | Johns Hopkins University | 2026-09-06 |
| SMARCA4/2 Inhibitor for POU2F3-Positive SCLC (NCT07551635) | Dana-Farber Cancer Institute | 2026-09-04 |
| A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of VG2025 Intravenous Injection in Subjects With Advanced Solid Tumors (NCT07682870) | Virogin Biotech Ltd. | 2026-09-04 |
| A Phase 2 Study of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia (NCT07681089) | Kiminori Kimura, MD | 2026-09-01 |
| Multicentre Study Evaluating the Efficacy of a 7-day Course of Doxycycline for the Treatment of Asymptomatic Anal Lymphogranuloma Venereum. (NCT07767422) | University Hospital, Bordeaux | 2026-09-01 |
| Mitochondrial Network Modulation Approach Using Hyperbaric Oxygen (HBO) Therapy and Nb-UVB for Treating Vitiligo (NCT07557693) | Centre Hospitalier Universitaire de Nice | 2026-09-01 |
| A Clinical Study of CT0596 CAR-T in Relapsed/Refractory Multiple Myeloma (NCT07760454) | UCARsgen Biotech Limited | 2026-09-01 |
| Study of Teverelix DP on Prostate Volume, Urinary Function and Clinical Outcomes Following Acute Urinary Retention (NCT07733934) | Antev Ltd. | 2026-09-01 |
| A Combination Therapy Strategy to Prevent Anti-PD-1 Therapy Resistance in Metastatic Ovarian Cancer Patients (NCT05479045) | Georgetown University | 2026-09-01 |
| Enfortumab Vedotin + Pembrolizumab Induction to Spare the Bladder in MIBC (NCT07663747) | The Netherlands Cancer Institute | 2026-09-01 |
| A Study of GM-XANTHO in Pressure Ulcer Patients (NCT05199077) | Xantho Biotechnology Co., LTD | 2026-09-01 |
| Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial (NCT07576725) | Fred Hutchinson Cancer Center | 2026-09-01 |
| CIMAvax-EGF With KRAS G12C Inhibitor for the Treatment of Advanced, KRAS G12C Mutated Non Small Cell Lung Cancer (NCT07543172) | Roswell Park Cancer Institute | 2026-09-01 |
| Birelentinib Plus R-CHOP in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma (TAI-SHAN19) (NCT07712588) | Dizal Pharmaceuticals | 2026-09-01 |
| Surgical Treatment for Gingival Recessions After Orthodontic Treatment (NCT07763808) | Aziz Aliyev Azerbaijan State Advanced Training Institute for Doctors | 2026-09-01 |
| SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer (NCT07322341) | University of Washington | 2026-09-01 |
| Shuganhuazhuo Formula for Advanced Hepatocellular Carcinoma With Damp-Heat Syndrome (NCT07691645) | Xiang-Qian | 2026-09-01 |
| Standard Treatment Associated With Phage Therapy Versus Placebo for Diabetic Foot Ulcers Infected by S. Aureus (NCT02664740) | Centre Hospitalier Universitaire de Nīmes | 2026-09-01 |
| A Study to Assess the Correct Dose, Safety and Efficacy of Empasiprubart in Adolescent Participants Aged 12 to Less Than 18 Years With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (NCT07638566) | argenx | 2026-09-01 |
| A Phase 2 Study on the Safety and Efficacy of the Anti-BAFF-R Monoclonal Antibody, ESG206, in Patients With Systemic Lupus Erythematosus (NCT07760155) | Shanghai Escugen Biotechnology Co., Ltd | 2026-09-01 |
| A Study of Propranolol to Treat Kaposi Sarcoma (NCT05797662) | AIDS Malignancy Consortium | 2026-09-01 |
| NCT + PD1 + Ketogenic Diet and/or Vitamin C for LARC (NCT07765667) | Sixth Affiliated Hospital, Sun Yat-sen University | 2026-09-01 |
| Dipyridamole for Early-Onset Preeclampsia: A Pilot Study of Feasibility, Pharmacokinetics, and Biological Effects (NCT07738562) | Hadassah Medical Organization | 2026-09-01 |
| Naive T Cell Deplete Grafts for GVHD Prevention in Non-Malignant Diseases (NCT07660783) | Fred Hutchinson Cancer Center | 2026-09-01 |
| Neoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle Invasive Bladder Cancer, TRIFECTA Trial (NCT07332351) | University of Washington | 2026-09-01 |
| Fluorescence Guided Focal Cortical Dysplasia Surgery (NCT07657975) | Hospices Civils de Lyon | 2026-09-01 |
| A Study to Assess the Efficacy and Safety of THB335 in Adults With Chronic Spontaneous Urticaria (CSU) (NCT07766499) | Calixis Inc. | 2026-09-01 |
| Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of QLS2319 in Healthy Subjects and Cancer Cachexia (NCT07735104) | Qilu Pharmaceutical Co., Ltd. | 2026-09-01 |
| Atomoxetine in Melanocortin Obesity Syndrome (NCT06899178) | Icahn School of Medicine at Mount Sinai | 2026-09-01 |
| Combination Immunotherapy Treatment for Locally Advanced Unresectable or Metastatic, PD-L1 Negative (CPS<10), gBRCA Negative, Triple Negative Breast Cancer Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 Therapy (NCT07762703) | BreakBio Corp | 2026-09-01 |
| Adaptive Chemotherapy for Pd-l1 High REsEctablE NSCLC: A Chemo-PHREE Trial (NCT07746388) | University of Maryland, Baltimore | 2026-09-01 |
| Semaglutide for Treatment of People With Methamphetamine Use Disorder: the SHIFT Study (NCT07509112) | Kirby Institute | 2026-09-01 |
| Redefine Study: A Study Evaluating the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder (NCT07570654) | COMPASS Pathways | 2026-09-01 |
| A Study of GFH276 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors and Pancreatic Ductal Adenocarcinoma (PDAC) Harboring RAS Mutation (NCT07678593) | Genfleet Therapeutics (Shanghai) Inc. | 2026-09-01 |
| Study of 18FET PET in Functional Pituitary Adenomas With Indeterminate MRI Findings (NCT07360548) | University Hospital, Lille | 2026-09-01 |
| Study of SG301 for Renal AMR After Transplantation (NCT07764627) | Hangzhou Sumgen Biotech Co., Ltd. | 2026-09-01 |
| Haploidentical Donor Hematopoietic Cell Transplant for Sickle Cell Disease (NCT07616154) | St. Jude Children's Research Hospital | 2026-09-01 |
| Evaluating the Safety and Immunogenicity of Polyvalent DNA and Recombinant gp120 Protein HIV Vaccine (PDPHV) in Healthy, HIV-uninfected Adults (NCT07675629) | Worcester HIV Vaccine | 2026-09-01 |
| Nemolizumab for LS (NCT07704775) | University of Texas Southwestern Medical Center | 2026-09-01 |
| The Selective Personalized Radio-Immunotherapy for Locally Advanced Non-Small Cell Lung Cancer Trial 2 (NCT07146230) | Montefiore Medical Center | 2026-09-01 |
| Disulfiram in Rheumatoid Arthritis (NCT07534332) | University of Oklahoma | 2026-09-01 |
| OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosili-cate in Heart Failure -Extension (OPRA-HF Extension) (NCT07576257) | Sahlgrenska University Hospital | 2026-09-01 |
| Zanzalintinib Efficacy Post Pluvicto® in Chemotherapy Naïve Metastatic Castration Resistant Prostate Cancer (NCT07623460) | Stuthi Perimbeti | 2026-09-01 |
| Human Umbilical Cord Mesenchymal Stem Cell Infusion for Type 2 Diabetic Nephropathy (NCT07769671) | The First People's Hospital of Changzhou | 2026-09-01 |
| Investigating Novel Interventions for Low Back Pain in US Military Veterans: A Randomized Controlled Adaptive Phase II Trial (NCT05935761) | VA Office of Research and Development | 2026-09-01 |
| aDAPt-ANOCA: Dapagliflozin for the Treatment of Angina With Non-Obstructive Coronary Artery Disease (ANOCA) (NCT07741890) | The Christ Hospital | 2026-09-01 |
| Impact of Duffy-null Associated Neutropenia on Chemotherapy Dosing (NCT07743086) | Barbara Ann Karmanos Cancer Institute | 2026-09-01 |
| Synaptic Mechanisms of Intermittent Theta Burst Stimulation for Major Depressive Disorder (NCT07593222) | Mclean Hospital | 2026-09-01 |
| Assessing the Mechanisms and Impact of a Novel Cannabinoid Product for Gynecologic Pain (NCT07728695) | Staci Gruber, Ph.D. | 2026-09-01 |
| Gene Therapy for Patients With Transfusion-Dependent β-Thalassemia (NCT07721480) | Prince of Wales Hospital, Shatin, Hong Kong | 2026-09-01 |